Schering-Plough selects ixPressa software for blister printing
Schering-Plough has signed up to use software developed by UK-based specialist ixPressia to improve the quality of its blister printing operations.
Schering-Plough has signed up to use software developed by UK-based specialist ixPressia to improve the quality of its blister printing operations.
US drugmaker Adventrx Pharmaceuticals is reducing its workforce to just 14 employees in a bid to preserve cash and refocus efforts on bioequivalence programmes for its lead candidates.
There is still no formal offer on the table for Canadian contract manufacturer Patheon from JLL Patheon Holdings, an investment group which currently owns around 29 per cent of the firm.
Cincinatti, US-based clinical research organization Kendle has cut back its revenue expectations for 2008, primarily as a result of the strengthening of the US dollar, in common with some of its peers in the CRO sector.
Wyeth Pharmaceuticals is continuing efforts to improve its capabilities in the formulation and delivery of RNA through a strategic partnership with Santaris Pharma.
A US HHS report on FDA oversight during trials has found that, with current procedures, the agency cannot tell whether drugmakers are disclosing complete financial information from all investigators who worked on a particular study.
Sanofi-Aventis Canada has licensed I-many’s suite of software for managing pharmaceutical contracts, with the IT company also performing installation, maintenance and support.